Fluorodopa (18F)

Fluorodopa (18F) Uses, Dosage, Side Effects, Food Interaction and all others data.

Fluorodopa F 18 is a fluorinated analog of levodopa used as a diagnostic agent for positron emission tomography (PET) in the evaluation of Parkinsonian syndromes. Fluorodopa F 18 PET is used adjunctly with other diagnostic investigations and serves primarily to visualize dopaminergic nerve terminals in the striatum.

Table Of contents

• Fluorodopa (18F)
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Fluorodopa (18F)
Generic	Fluorodopa (18F)
Fluorodopa (18F) Other Names	Fluorodopa (18F), Fluorodopa F-18
Type
Formula	C9H10FNO4
Weight	Average: 214.183 Monoisotopic: 214.061920473
Groups	Approved, Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Fluorodopa F 18 is indicated for use with positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS).

Fluorodopa (18F) is also used to associated treatment for these conditions: Parkinsonian Syndromes

Food Interaction

• Take on an empty stomach. Before fluorodopa F18 administration do not eat or drink anything, except for water, for at least 4 hours.

Half Life

The plasma half-life following intravenous administration is approximately 1-3 hours.

Clearance

The agent is cleared from blood and tissue within 24 hours following administration.

Elimination Route

Approximately 80% of the administered radioactivity is eliminated in the urine.

Innovators Monograph

You find simplified version here Fluorodopa (18F)